EU
Pfizer to consider stockpiling medicines in preperation for no-deal Brexit
August 6, 2018Sales and Marketing EU, MSD, Pfizer, Sanofi, brexit, stockpiling
Pfizer is considering joining AstraZeneca, Sanofi and MSD in stockpiling medicines in preparation for a hard Brexit, it has emerged. …
Irish trade lobby warns EU amendments could threaten pharma industry in Ireland, critics contest
August 6, 2018Sales and Marketing EU, IPHA, Ireland, biosimilars, generics, intellectual property, trade lobby
The Irish Pharmaceutical Healthcare Association (IPHA) has warned that changes to existing intellectual property legislation could threaten innovation and deter …
Top Ten most popular articles on Pharmafile.com this week
August 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, GSK, Sanofi, brexit, pharmafile, top 10
While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …
Pfizer notches two EU approvals, including Herceptin biosimilar
August 1, 2018Research and Development, Sales and Marketing Cancer, EMA, EU, Genetech, Herceptin, Pfizer, Trazimera, Xeljanz, biosimilar, breast cancer, pharma
Pfizer is patting itself on the back after securing two new approvals in Europe within 24 hours: Xeljanz (tofacitinib citrate) …
CHMP recommends Novartis’ CAR-T therapy Kymriah for EU approval
July 5, 2018Sales and Marketing CAR-T, CHMP, EMA, EU, Kymriah, Novartis, pharma
The Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Medicines Agency (EMA) approve Novartis’ CAR-T …
Pfizer’s Xeljanz scores EU approval for active psoriatic arthritis
June 29, 2018Medical Communications, Sales and Marketing EU, Europe, Pfizer, Xeljanz, pharma, psoriatic arthritis
Pfizer has announced that the European Commission (EC) has approved Xeljanz in combination with methotrexate (MTX) for the treatment of …
European Commission greenlights Gilead’s Biktarvy for HIV-1
June 25, 2018Sales and Marketing Biktarvy, EU, Europe, European Commission, HIV, HIV-1, pharma
Good news for Gilead and HIV patients across the European Union today as the prominent pharma firm announced that its …
Novartis’ Sandoz scores EU approval for Remicade biosimilar
May 24, 2018Sales and Marketing EU, Europe, Novartis, Remicade, Sandoz, Zessly, pharma
The European Commission has given its approval to Sandoz, Novartis’ generics and biosimilars unit, for its biosimilar version of Janssen’s …
ViiV’s two-drug regimen gets EU approval for HIV-1
May 22, 2018Manufacturing and Production, Sales and Marketing EMA, EU, Europe, HIV, Juluca, ViiV Healthcare, pharma
ViiV Healthcare has announced that its HIV therapy Juluca (dolutegravir/rilpivirine) has been awarded marketing authorisation in the EU from the …
Six reasons why UK pharma has more to gain, than fear, from Brexit
March 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, biotech, brexit, drugs, hard Brexit, pharma, pharmaceutical
There are good reasons to think exiting the EU represents a major opportunity for this dynamic and world-leading industry, argues …
Takeda and TiGenix’s Alofisel becomes first donor-derived stem cell therapy approved in Europe
March 26, 2018Sales and Marketing Crohn’s disease, EU, Europe, European Commission, Takeda, TiGenix, crohn's disease, pharma
The European Commission has awarded approval to Takeda and TiGenix’s allogeneic expanded adipose-derived stem cell (eASC) therapy Alofisel (darvadstrocel) for …
GSK’s shingles vaccine secures EU and Japan approvals
March 26, 2018Sales and Marketing EU, Europe, GSK, Japan, Shingrix, pharma, shingles
GlaxoSmithKline has announced that its shingles vaccine Shingrix has secured approval in two new regions: in Europe, for the prevention …
Bayer-Monsanto deal one step closer, after EU nod
March 22, 2018Sales and Marketing Bayer, EU, biotech, drugs, monsanto, pharma, pharmaceutical
The merger between Bayer and agricultural giant, Monsanto, is inching closer to completion after the EU Commission won EU antitrust …
Celltrion’s Herceptin biosimilar seals EU approval
February 15, 2018Sales and Marketing EU, Europe, Herceptin, Herzuma, celltrion, pharma
Herzuma, Celltrion’s biosimilar version of Roche/Genentech’s blockbuster immunotherapy Herceptin, has been awarded approval from the European Commission, the company has …
Eli Lilly’s Taltz get EU approval in psoriatic arthritis subgroup
January 24, 2018Research and Development, Sales and Marketing EU, Eli Lilly, Europe, European Commission, Taltz, pharma, psoriatic arthritis
Eli Lilly has revealed that its IgG4 monoclonal antibody Taltz (ixekizumab) has been awarded marketing approval from the European Commission …
Latest content
